Literature DB >> 30574617

TLR1 and PRKAA1 Gene Polymorphisms in the Development of Atrophic Gastritis and Gastric Cancer.

Gintare Dargiene1, Greta Streleckiene2, Jurgita Skieceviciene1, Marcis Leja3, Alexander Link4, Thomas Wex5, Limas Kupcinskas1, Peter Malfertheiner4, Juozas Kupcinskas6.   

Abstract

BACKGROUND AND AIMS: Previous genome-wide association studies showed that genetic polymorphisms in toll-like receptor 1 (TLR1) and protein kinase AMP-activated alpha 1 catalytic subunit (PRKAA1) genes were associated with gastric cancer (GC) or increased Helicobacter pylori (H. pylori) infection susceptibility. The aim of this study was to evaluate the association between TLR1 and PRKAA1 genes polymorphisms and H. pylori infection, atrophic gastritis (AG) or GC in the European population.
METHODS: Single-nucleotide polymorphisms (SNPs) were analysed in 511 controls, 340 AG patients and 327 GC patients. TLR1 C>T (rs4833095) and PRKAA1 C>T (rs13361707) were genotyped by the real-time polymerase chain reaction. H. pylori status was determined by testing for anti-H. pylori IgG antibodies in the serum.
RESULTS: The study included 697 (59.2%) H. pylori positive and 481 (40.8%) H. pylori negative cases. We observed similar distribution of TLR1 and PRKAA1 alleles and genotypes in H. pylori positive and negative cases. TLR1 and PRKAA1 SNPs were not linked with the risk of AG. TC genotype of TLR1 gene was more prevalent in GC patients compared to the control group (29.7% and 22.3% respectively, p=0.002). Carriers of TC genotype had a higher risk of GC (aOR=1.89, 95% CI: 1.26-2.83, p=0.002). A similar association was observed in a dominant inheritance model for TLR1 gene SNP, where comparison of CC+TC vs. TT genotypes showed an increased risk of GC (aOR=1.86, 95% CI: 1.26-2.75, p=0.002). No association between genetic polymorphism in PRKAA1 gene and GC was observed.
CONCLUSIONS: TLR1 rs4833095 SNP was associated with an increased risk of GC in a European population, while PRKAA1 rs13361707 genetic variant was not linked with GC. Both genetic polymorphisms were not associated with H. pylori infection susceptibility or the risk of AG.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30574617     DOI: 10.15403/jgld.2014.1121.274.tlr

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  7 in total

1.  The Clinical Relevance of Frequent Germline Genetic Variants Detected by Targeted Sequencing in Patients With Rectal Adenocarcinoma (READ).

Authors:  Kevin Chih-Yang Huang; Shu-Fen Chiang; Tao-Wei Ke; William Tzu-Liang Chen; Tsung-Wei Chen; Kun-San Clifford Chao
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

2.  High Expression of Citron Kinase Contributes to the Development of Esophageal Squamous Cell Carcinoma.

Authors:  Wenfeng Lu; Yun Dong; Qing Cui; Yuhan Wang; Xiwen Yang; Xiaoyue Cai; Ming Zhang
Journal:  Front Genet       Date:  2021-07-07       Impact factor: 4.599

3.  Association of Long Non-Coding RNA Polymorphisms with Gastric Cancer and Atrophic Gastritis.

Authors:  Vytenis Petkevicius; Greta Streleckiene; Kotryna Balciute; Alexander Link; Marcis Leja; Peter Malfertheiner; Jurgita Skieceviciene; Juozas Kupcinskas
Journal:  Genes (Basel)       Date:  2020-12-15       Impact factor: 4.096

Review 4.  Gastric epithelial histology and precancerous conditions.

Authors:  Hang Yang; Wen-Juan Yang; Bing Hu
Journal:  World J Gastrointest Oncol       Date:  2022-02-15

Review 5.  The Role of the Heat-Shock Proteins in Esophagogastric Cancer.

Authors:  Francisco Tustumi; Gabriel Andrade Agareno; Ricardo Purchio Galletti; Rafael Benjamim Rosa da Silva; Julia Grams Quintas; Lucas de Abreu Sesconetto; Daniel José Szor; Nelson Wolosker
Journal:  Cells       Date:  2022-08-27       Impact factor: 7.666

Review 6.  Molecular Alterations in Gastric Intestinal Metaplasia.

Authors:  Paulius Jonaitis; Limas Kupcinskas; Juozas Kupcinskas
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

7.  PRKAA1 rs13361707 C/T polymorphism confers decreased susceptibility to esophageal cancer: A case-control study.

Authors:  Cheng-Lin Li; Jian-Qiang Zhao; Bao Zang
Journal:  J Clin Lab Anal       Date:  2020-06-02       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.